Literature DB >> 22446893

Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?

Kerstin Hackmack1, Martin Weygandt, Jens Wuerfel, Caspar F Pfueller, Judith Bellmann-Strobl, Friedemann Paul, John-Dylan Haynes.   

Abstract

The association between common neuroradiological markers of multiple sclerosis (MS) and clinical disability is weak, a phenomenon known as the clinico-radiological paradox. Here, we investigated to which degree it is possible to predict individual disease profiles from conventional magnetic resonance imaging (MRI) using multivariate analysis algorithms. Specifically, we conducted cross-validated canonical correlation analyses to investigate the predictive information contained in conventional MRI data of 40 MS patients for the following clinical parameters: disease duration, motor disability (9-Hole Peg Test, Timed 25-Foot Walk Test), cognitive dysfunction (Paced Auditory Serial Addition Test), and the expanded disability status scale (EDSS). It turned out that the information in the spatial patterning of MRI data predicted the clinical scores with correlations of up to 0.80 (p < 10(-9)). Maximal predictive information for disease duration was identified in the precuneus and somatosensory cortex. Areas in the precuneus and precentral gyrus were maximally informative for motor disability. Cognitive dysfunction could best be predicted using data from the angular gyrus and superior parietal lobe. For EDSS, the inferior frontal gyrus was maximally informative. In conclusion, conventional MRI is highly predictive of clinical disability in MS when pattern-based algorithms are used for prediction. Thus, the so-called clinico-radiological paradox is not apparent when using suitable analysis techniques.

Entities:  

Mesh:

Year:  2012        PMID: 22446893     DOI: 10.1007/s00415-012-6475-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  44 in total

Review 1.  MRI techniques to monitor MS evolution: the present and the future.

Authors:  Massimo Filippi; Robert I Grossman
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

2.  Canonical correlation analysis: an overview with application to learning methods.

Authors:  David R Hardoon; Sandor Szedmak; John Shawe-Taylor
Journal:  Neural Comput       Date:  2004-12       Impact factor: 2.026

Review 3.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 4.  Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment.

Authors:  C Lucchinetti; W Brück; J Noseworthy
Journal:  Curr Opin Neurol       Date:  2001-06       Impact factor: 5.710

Review 5.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

6.  High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables.

Authors:  Ying Wang; Yong Fan; Priyanka Bhatt; Christos Davatzikos
Journal:  Neuroimage       Date:  2010-01-04       Impact factor: 6.556

7.  Diagnosing different binge-eating disorders based on reward-related brain activation patterns.

Authors:  Martin Weygandt; Axel Schaefer; Anne Schienle; John-Dylan Haynes
Journal:  Hum Brain Mapp       Date:  2011-08-30       Impact factor: 5.038

8.  Automatic classification of MR scans in Alzheimer's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Carlton Chu; Bogdan Draganski; Rachael I Scahill; Jonathan D Rohrer; Nick C Fox; Clifford R Jack; John Ashburner; Richard S J Frackowiak
Journal:  Brain       Date:  2008-01-17       Impact factor: 13.501

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

Authors:  M Wylezinska; A Cifelli; P Jezzard; J Palace; M Alecci; P M Matthews
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  17 in total

1.  Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Authors:  B Mark Keegan; Timothy J Kaufmann; Brian G Weinshenker; Orhun H Kantarci; William F Schmalstieg; M Mateo Paz Soldan; Eoin P Flanagan
Journal:  Neurology       Date:  2016-09-16       Impact factor: 9.910

2.  Criteria improving multiple sclerosis diagnosis at the first MRI.

Authors:  Nathalie Caucheteux; Adil Maarouf; Margaux Genevray; Emmanuelle Leray; Romain Deschamps; Marie P Chaunu; Laure Daelman; Jean C Ferré; Olivier Gout; Jean Pelletier; Laurent Pierot; Gilles Edan; Ayman Tourbah
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 3.  Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Authors:  Maria Pia Sormani; Matteo Pardini
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

4.  Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis.

Authors:  Yael Backner; Joseph Kuchling; Said Massarwa; Timm Oberwahrenbrock; Carsten Finke; Judith Bellmann-Strobl; Klemens Ruprecht; Alexander U Brandt; Hanna Zimmermann; Noa Raz; Friedemann Paul; Netta Levin
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

Review 5.  Autoimmune diseases of the brain, imaging and clinical review.

Authors:  Ghazal Shadmani; Tyrell J Simkins; Reza Assadsangabi; Michelle Apperson; Lotfi Hacein-Bey; Osama Raslan; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-09-07

6.  Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Authors:  Martin Weygandt; Lil Meyer-Arndt; Janina Ruth Behrens; Katharina Wakonig; Judith Bellmann-Strobl; Kerstin Ritter; Michael Scheel; Alexander U Brandt; Christian Labadie; Stefan Hetzer; Stefan M Gold; Friedemann Paul; John-Dylan Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 7.  Multiple sclerosis imaging: recent advances.

Authors:  Maria A Rocca; Roberta Messina; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

8.  Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.

Authors:  Sveinung Fjær; Lars Bø; Arvid Lundervold; Kjell-Morten Myhr; Tina Pavlin; Oivind Torkildsen; Stig Wergeland
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

9.  Probabilistic atlases of default mode, executive control and salience network white matter tracts: an fMRI-guided diffusion tensor imaging and tractography study.

Authors:  Teresa D Figley; Navdeep Bhullar; Susan M Courtney; Chase R Figley
Journal:  Front Hum Neurosci       Date:  2015-11-03       Impact factor: 3.169

10.  Determinants of disability in multiple sclerosis: an immunological and MRI study.

Authors:  Paola Tortorella; Maria Marcella Laganà; Marina Saresella; Eleonora Tavazzi; Maria Giulia Preti; Cristian Ricci; Francesca Baglio; Ivana Marventano; Federica Piancone; Giuseppe Baselli; Pietro Cecconi; Domenico Caputo; Mario Clerici; Marco Rovaris
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.